Medexus Pharmaceuticals Inc Financial Overview
Medexus Pharmaceuticals Inc's market cap is currently C$85.91M. The company's EPS TTM is C$-0.0140502916; its P/E ratio is 123.15; Medexus Pharmaceuticals Inc is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is C$-0.03. See an overview of income statement, balance sheet, and cash flow financials.
